Matches in Wikidata for { <http://www.wikidata.org/entity/Q66063939> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q66063939 description "clinical trial" @default.
- Q66063939 description "ensayu clínicu" @default.
- Q66063939 description "klinisch onderzoek" @default.
- Q66063939 description "клінічне випробування" @default.
- Q66063939 name "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 name "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 type Item @default.
- Q66063939 label "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 label "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 prefLabel "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 prefLabel "Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 P1050 Q66063939-18AD3F62-49EA-41D6-9A71-147D00B6F782 @default.
- Q66063939 P1050 Q66063939-593C6375-9CCB-41DC-AFCB-3ACA6FAD69EE @default.
- Q66063939 P1050 Q66063939-EE550F4F-4540-4E2C-96FB-BF48B06D52BD @default.
- Q66063939 P1132 Q66063939-03FD116A-C984-4A60-A14C-68A280102722 @default.
- Q66063939 P1476 Q66063939-AC7D53AF-30AC-4442-8915-1DCD2D9B5125 @default.
- Q66063939 P17 Q66063939-8DA94F09-5D46-40E4-A83A-317A8CC91764 @default.
- Q66063939 P2899 Q66063939-DE6BD1D0-FD17-4EEA-A443-F1FEDA79BA1F @default.
- Q66063939 P3098 Q66063939-ADDBA966-F45E-49E9-9325-6DDDE4170679 @default.
- Q66063939 P31 Q66063939-DFC0850E-9FC5-4BDC-B86A-BF814A8A41D5 @default.
- Q66063939 P4844 Q66063939-04FF44C7-AD22-4253-A0CF-9DA6CAEEF446 @default.
- Q66063939 P4844 Q66063939-1E70E1C8-AE07-4156-9C35-873FC143AD0A @default.
- Q66063939 P4844 Q66063939-3F79C259-3588-4A6C-A275-90265986DC2D @default.
- Q66063939 P4844 Q66063939-44D30333-F659-4FC2-BB88-EDBCE8A47FF3 @default.
- Q66063939 P4844 Q66063939-72C18B95-3C8A-4540-A027-EEDB25A5BF5F @default.
- Q66063939 P4844 Q66063939-93E9E54C-49B3-4AD9-8848-EE494656EEDA @default.
- Q66063939 P4844 Q66063939-B3737CDB-2588-427A-ABE5-8748F708E9B4 @default.
- Q66063939 P4844 Q66063939-FBF015B4-AD3D-4B9F-8417-F5E3596461ED @default.
- Q66063939 P580 Q66063939-82FFF54F-E450-4122-8ADC-7D38AC851929 @default.
- Q66063939 P582 Q66063939-295670B5-A46E-470B-A20A-CA7EF5CF34E2 @default.
- Q66063939 P6099 Q66063939-22424480-FE4D-4A43-9197-AE87AD056BE9 @default.
- Q66063939 P6153 Q66063939-B9094AC3-8888-4FEA-A052-81239A0D9D7A @default.
- Q66063939 P8363 Q66063939-E07623D6-3A43-4800-9BBB-EB6EF0B7B4FB @default.
- Q66063939 P859 Q66063939-FEBCF127-50C6-4ECB-81ED-1263AA8B01A6 @default.
- Q66063939 P1050 Q1016605 @default.
- Q66063939 P1050 Q208414 @default.
- Q66063939 P1050 Q29496 @default.
- Q66063939 P1132 "+36" @default.
- Q66063939 P1476 "A Phase I Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin Plus Escalating Doses of Inotuzumab Ozogamicin (DA-EPOCH-InO) in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia" @default.
- Q66063939 P17 Q30 @default.
- Q66063939 P2899 "+18" @default.
- Q66063939 P3098 "NCT03991884" @default.
- Q66063939 P31 Q30612 @default.
- Q66063939 P4844 Q18936 @default.
- Q66063939 P4844 Q27260984 @default.
- Q66063939 P4844 Q29004943 @default.
- Q66063939 P4844 Q408524 @default.
- Q66063939 P4844 Q412323 @default.
- Q66063939 P4844 Q421193 @default.
- Q66063939 P4844 Q424972 @default.
- Q66063939 P4844 Q50429626 @default.
- Q66063939 P580 "2019-07-31T00:00:00Z" @default.
- Q66063939 P582 "2024-02-28T00:00:00Z" @default.
- Q66063939 P6099 Q5452194 @default.
- Q66063939 P6153 Q219563 @default.
- Q66063939 P8363 Q78089383 @default.
- Q66063939 P859 Q219563 @default.